WAT — WATERS CORP /DE/

—
NYSE · Unknown · Unknown · CIK 1000697 ·
Last close
$449.78
Market Cap
$44.21B
52W High
$483.33
52W Low
$282.77
ADV30
949,666
Next earnings
—
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 1,645,000,000 734,000,000 -37,000,000 -136,000,000 24,751,000,000 539,000,000 9,556,000,000
Mar 2026 1,267,000,000 588,000,000 -47,000,000 -72,000,000 24,531,000,000 462,000,000 9,239,000,000
Dec 2025 932,362,000 569,498,000 270,516,000 225,214,000 5,076,550,000 587,831,000 2,515,308,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$479,553,000
Investing CF
$-58,133,000
Financing CF
$-275,664,000
CapEx
$-188,973,000
Dividends Paid
—
Buybacks
$-15,144,000
EPS Diluted TTM
$2.33
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$10,304,000,000
Inventory
$1,324,000,000
Receivables
$1,464,000,000
ST Investments
—
EBIT TTM
$290,468,000
Pretax Income TTM
$109,181,000
Interest Exp TTM
$181,287,000
Analysts
23

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,610,286,080
EBITDA
$1,758,048,000
Free Cash Flow
$-169,077,632
Enterprise Value
$50,157,961,216
Total Cash
$593,000,000
Total Debt
$5,514,999,808
Shares Out
98,285,634
Trailing EPS
$2.39
Book Value
$155.60
ROE
1.1%
ROA
3.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 3,165,286,000 802,588,000 642,629,000 5,076,550,000 2,515,308,000 2,561,242,000 652,555,000
Dec 2024 2,958,387,000 837,921,000 637,834,000 4,553,795,000 2,725,288,000 1,828,507,000 762,123,000
Dec 2023 2,956,416,000 817,676,000 642,234,000 4,626,854,000 3,476,513,000 1,150,341,000 602,809,000
Dec 2022 2,971,956,000 883,192,000 707,755,000 3,281,453,000 2,776,965,000 504,488,000 611,661,000

TTM Snapshot

Revenues TTM
$4,644,249,000
NetIncome TTM
$166,137,000
OpCashFlow TTM
—
Assets (Latest)
$24,751,000,000
Forward EPS
$16.53

Peers — same industry

TickerNameMarket CapLastDaily %
TRI THOMSON REUTERS CORP /CAN/ $45.13B $104.17 —
NKE NIKE, Inc. $43.10B $35.85 —
ROK ROCKWELL AUTOMATION, INC $42.94B $391.26 —
ROP ROPER TECHNOLOGIES INC $46.74B $471.92 —
VYLR Vylor Inc. $46.85B $70.21 —

News headlines (Yahoo Finance, 1h cache)

Waters Corporation to Present at the 9th Annual Evercore Healthcare Conference
2026-11-17 14:00 · Yahoo
Simple HealthKit Partners with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients
2026-11-17 12:00 · Yahoo
What Was Waters Telling You Before Its Stock Ran?
2026-11-17 00:53 · Yahoo
Waters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and Lymphoma
2026-11-10 13:00 · Yahoo
Waters Q3 Earnings Call Highlights
2026-11-04 11:14 · Yahoo
Waters (WAT) Stock Could Be 27% Overvalued Despite Raised Guidance
2026-11-04 06:17 · Yahoo
Waters Corp (WAT) Q3 2026 Earnings Call Highlights: Raised Guidance, 21% EPS Growth and a ...
2026-11-03 21:06 · Yahoo
Is Waters (WAT) Fully Priced As Mixed Earnings Reset Its Valuation Story?
2026-11-03 19:13 · Yahoo
Waters Corporation Q3 2026 Earnings Call Summary
2026-11-03 18:35 · Yahoo
Earnings Beat Might Change The Case For Investing In Waters Stock (WAT)
2026-11-03 18:09 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.